Bristol-Myers Squibb buy StockNews.com
Start price
29.07.23
/
50%
€55.90
Target price
29.07.24
-
Performance (%)
-19.63%
End price
30.07.24
€44.93
Summary
This prediction ended on 30.07.24 with a price of €44.93. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. Dividends of €2.19 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | -0.290% | -0.290% | -15.939% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by StockNews_com for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten